Lipocine Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2017 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Lipocine Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q3 2024.
- Lipocine Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $412K, a 4.91% increase year-over-year.
- Lipocine Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $1.24M.
- Lipocine Inc. annual Nonoperating Income (Expense) for 2023 was $1.58M, a 16% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)